Literature DB >> 26151320

All aboard: Will molecular tumor boards help cancer patients?

Jeanne Erdmann.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26151320     DOI： 10.1038/nm0715-655

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  1 in total

1.  Molecular tumor board: the University of California-San Diego Moores Cancer Center experience.

Authors:  Maria Schwaederle; Barbara A Parker; Richard B Schwab; Paul T Fanta; Sarah G Boles; Gregory A Daniels; Lyudmila A Bazhenova; Rupa Subramanian; Alice C Coutinho; Haydee Ojeda-Fournier; Brian Datnow; Nicholas J Webster; Scott M Lippman; Razelle Kurzrock
Journal:  Oncologist       Date:  2014-05-05
  1 in total
  8 in total

Review 1.  Off-label use of targeted therapies in oncology.

Authors:  Dominique Levêque
Journal:  World J Clin Oncol       Date:  2016-04-10

2.  Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee Experience.

Authors:  Todd C Knepper; Gillian C Bell; J Kevin Hicks; Eric Padron; Jamie K Teer; Teresa T Vo; Nancy K Gillis; Neil T Mason; Howard L McLeod; Christine M Walko
Journal:  Oncologist       Date:  2017-02-08

3.  Validation and Application of a Custom-Designed Targeted Next-Generation Sequencing Panel for the Diagnostic Mutational Profiling of Solid Tumors.

Authors:  Guy Froyen; An Broekmans; Femke Hillen; Karin Pat; Ruth Achten; Jeroen Mebis; Jean-Luc Rummens; Johan Willemse; Brigitte Maes
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

4.  PIPELINEs: Creating Comparable Clinical Knowledge Efficiently by Linking Trial Platforms.

Authors:  M R Trusheim; A A Shrier; Z Antonijevic; R A Beckman; R K Campbell; C Chen; K T Flaherty; J Loewy; D Lacombe; S Madhavan; H P Selker; L J Esserman
Journal:  Clin Pharmacol Ther       Date:  2016-10-19       Impact factor: 6.875

5.  The fuzzy world of precision medicine: deliberations of a precision medicine tumor board.

Authors:  Sarah A McGraw; Judy Garber; Pasi A Jänne; Neal Lindeman; Nelly Oliver; Lynette M Sholl; Eliezer M Van Allen; Nikhil Wagle; Levi A Garraway; Steven Joffe; Stacy W Gray
Journal:  Per Med       Date:  2016-12-15       Impact factor: 2.512

Review 6.  Implementation and utilization of the molecular tumor board to guide precision medicine.

Authors:  Shuko Harada; Rebecca Arend; Qian Dai; Jessica A Levesque; Thomas S Winokur; Rongjun Guo; Martin J Heslin; Lisle Nabell; L Burt Nabors; Nita A Limdi; Kevin A Roth; Edward E Partridge; Gene P Siegal; Eddy S Yang
Journal:  Oncotarget       Date:  2017-06-14

7.  "Cancer 2015": A Prospective, Population-Based Cancer Cohort-Phase 1: Feasibility of Genomics-Guided Precision Medicine in the Clinic.

Authors:  John P Parisot; Heather Thorne; Andrew Fellowes; Ken Doig; Mark Lucas; John J McNeil; Brett Doble; Alexander Dobrovic; Thomas John; Paul A James; Lara Lipton; David Ashley; Theresa Hayes; Paul McMurrick; Gary Richardson; Paula Lorgelly; Stephen B Fox; David M Thomas
Journal:  J Pers Med       Date:  2015-10-29

8.  Molecular Tumor Boards: Ethical Issues in the New Era of Data Medicine.

Authors:  Henri-Corto Stoeklé; Marie-France Mamzer-Bruneel; Charles-Henry Frouart; Christophe Le Tourneau; Pierre Laurent-Puig; Guillaume Vogt; Christian Hervé
Journal:  Sci Eng Ethics       Date:  2017-03-09       Impact factor: 3.525
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.